Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

The fraudulent products claim to be made by Pfizer, a major pharmaceutical company, but tests show they are completely fake.